Menaquinone-7 as a novel pharmacological therapy in the treatment of rheumatoid arthritis: A clinical study

European Journal of Pharmacology

Volumn 761, Issue , 2015, Pages 273-278

  Abdel Rahman, Mahran S ^a,b   Alkady, Eman A M ^b   Ahmed, Sameh ^a,c  

^a TAIBAH UNIVERSITY   (Saudi Arabia)

^b Assiut University Faculty of Medicine   (Egypt)

^c Assiut University   (Egypt)

Author keywords

DAS28 ESR; Matrix metalloproteinase; Menaquinone 7; Rheumatoid arthritis; ucOC

Indexed keywords

C REACTIVE PROTEIN; MENAQUINONE; MENAQUINONE 7; OSTEOCALCIN; STROMELYSIN; UNCLASSIFIED DRUG; ANTIRHEUMATIC AGENT; BIOLOGICAL MARKER; FARNOQUINONE; MICROCAPSULE; VITAMIN MK 7;

ADULT; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAS28; DISEASE ACTIVITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG MONITORING; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; ANALOGS AND DERIVATIVES; ARTHRITIS, RHEUMATOID; BLOOD; COMBINATION DRUG THERAPY; DISABILITY; DRUG ADMINISTRATION; EGYPT; MICROCAPSULE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOMARKERS; BLOOD SEDIMENTATION; CAPSULES; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; DRUG THERAPY, COMBINATION; EGYPT; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VITAMIN K 2;

EID: 84934886558     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.06.014     Document Type: Article

References (33)

1. S. Ahmed, N. Kishikawa, K. Ohyama, T. Imazato, Y. Ueki, and N. Kurda Selective chemiluminescence method for monitoring of vitamin K homologues in rheumatoid arthritis patients Talanta 85 2011 230 236
2. Y. Akiyama, K. Hara, T. Tajima, S. Murota, and I. Morita Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow culture Eur. J. Pharmacol. 263 1994 181 185
3. F.C. Arnett, S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, and N.S. Cooper The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum. 11 1988 315 324
4. E. Choy Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis Rheumatology (Oxford) 51 Suppl. 5 2012 v3 v11
5. K. Ebina, K. Shi, M. Hirao, S. Kaneshiro, T. Morimoto, K. Koizumi, H. Yoshikawa, and J. Hashimoto Vitamin K2 administration is associated with decreased disease activity in patients with rheumatoid arthritis Mod. Rheumatol. 23 2013 1001 1007
6. S. Firestein. Evolving concepts of rheumatoid arthritis Nature 423 2003 356 361
7. N. Furusyo, T. Ihara, T. Hayashi, H. Ikezaki, K. Toyoda, and E. Ogawa The serum undercarboxylated osteocalcin level and the diet of Japanese population: results from the Kyushu and Okinawa population study (KOPS) Endocrine 43 2013 635 642
8. C.H. Hennekens, and J.E. Buring Epidemiology in Medicine 1987 Lippincott Williams & Wilkins Boston, MA
9. M. Hirao, J. Hashimoto, W. Ando, T. Ono, and H. Yoshikawa Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women J. Bone Miner. Metab. 26 2008 260 264
10. M. Kaneki, S. Hedges, T. Hosoi, S. Fujiwara, A. Lyons, N. Ishida, M. Nakagawa, M. Takechi, Y. Sano, Y. Mizuno, S. Hoshino, M. Miyao, S. Inoue, K. Horiki, M. Shiraki, Y. Ouchi, and H. Orimo Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk Nutrition 17 2001 315
11. J. Knapen, K. Hamulyak, and C. Vermeer The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion Ann. Intern. Med. 111 1989 1001 1005
12. A. Kobayashi, S. Naito, H. Enomoto, T. Shiomoi, T. Kimura, K. Obata, K. Inoue, and Y. Okada Serum levels of matrix metalloproteinase 3 (stromelysin) for monitoring synovitis in rheumatoid arthritis Arch. Pathol. Lab. Med. 131 2007 563 570
13. A. Larsen, K. Dale, and M. Eek Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films Acta Radiol. Diagn. (Stockh) 18 1977 481 491
14. Y. Liu, A.N. Nelson, and J.J. Lipsky Vitamin K-dependent carboxylase: mRNA distribution and effects of vitamin K-deficiency and warfarin treatment Biochem. Biophys. Res. Commun. 224 1996 549 554
15. T. Matsui, Y. Kuga, A. Kaneko, J. Nishino, Y. Eto, N. Chipa, M. Yasuda, K. Saisho, K. Shimada, and S. Tohma Disease activity score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates (EULAR) response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan Ann. Rheum. Dis. 66 2007 1221 1226
16. B. Merle, and P.D. Delmas Normal carboxylation of circulating osteocalcin (bone Gla-protein) in Paget's disease of bone Bone Miner. 11 1990 237 245
17. L. Nielung, R. Christensen, B. Danneskiold-Samsoe, H. Bliddal, C. Cato Holm, K. Ellegaard, H. Slott Jensen, and E.-M. Bartels Validity and agreement between the 28 joint disease activity score based on C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis Arhthritis 2015 2015 1 6
18. K. Obata, K. Iwata, Y. Okada, Y. Kohrin, E. Ohuchi, S. Yoshida, M. Shinmei, and T. Hayakawa A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies Clin. Chim. Acta 211 1-2 1992 59 72
19. H. Okamoto, K. Shidara, D. Hoshi, and N. Kamatani Antiarthritis effects of vitamin K(2) (menaquinone-4) - a new potential therapeutic strategy for rheumatoid arthritis FEBS J. 274 2007 4588 4594
20. H. Okamoto Vitamin K and rheumatoid arthritis: critical review Life 60 6 2008 355 361
21. K. Pucaj, H. Rasmussen, M. Moller, and T. Preston Safety and toxicological evaluation of a synthetic vitamin K2, menaquinone-7 Toxicol. Mech. Methods 21 2011 520 532
22. Z. Qu, C.H. Garcia, L.M. O'Rourke, S.R. Planck, M. Kohli, and J.T. Rosenbaum Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining Arthritis Rheum. 37 1994 212 220
23. T. Sato, L. Schrgers, and K. Uenishi Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women Nutr. J. 11 2012 93
24. L.J. Schurgers, K.J. Teunissen, K. Hamulyák, M.H. Knapen, H. Vik, and C. Vermeer Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7 Blood 109 2007 3279 3283
25. M. Shearer Vitamin K Lancet 345 1995 229 234
26. M. Shiraki, and A. Itabashi A short-term menatetrenone therapy increase gamma carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study J. Bone Miner. Metab. 27 2009 333 340
27. M. Shiraki, Y. Shiraki, C. Aoki, and M. Miura Vitamin K2 (menatetrone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis J. Bone Miner. Res. 15 2000 515 521
28. A. So, A. Chamot, V. Peclat, and J.-C. Gerster Serum MMP-3 in rheumatoid arthritis: correlation with systemic inflammation but not with erosive status Rheumatology 38 1999 407 410
29. L.J. Sokoll, M.E. O'Brien, M.E. Camilo, and J.A. Sadowski undercarboxylated osteocalcin and development of a method to determine vitamin K status Clin. Chem. 41 1995 1121 1128
30. J.W. Suttie Synthesis of vitamin K-dependent proteins FASEB J. 7 1993 445 452
31. K. Suzuki, S. Tsuji, Y. Fukushima, T. Nakase, M. Hamada, T. Tomita, and H. Yoshikawa Clinical results of alendronate monotherapy and combined therapy with menatetrenone (VitK2) in postmenopausal RA patients Mod. Rheumatol. 23 2013 450 455
32. A. Urano, M. Hotta, R. Ohwada, and M. Araki Vitamin K deficiency evaluated by serum levels of undercarboxylated osteocalcin in patients with anorexia nervosa with bone loss Clin. Nutr. 34 2015 443 448
33. M. Yamauchi, T. Yamauchi, K. Nawata, S. Takaoka, and T. Sugimoto Relationships between undercarboxylated osteocalcin and vitamin K intakes, bone turnover, and bone mineral density in healthy women Clin. Nutr. 29 2010 761 765